Search

everythinglearnresearchcommunity

for

Search:↓

Nourkrin® with Marilex® may increase hair count by 35.7% in postpartum hair loss.

Fetuin A levels are higher in PCOS patients, while asprosin levels show no difference.

Lipedema is a painful fat disorder in women that's hard to treat, often worsens with hormonal changes, and requires symptom-focused therapies.

Growth Factor Concentrate is more effective than Platelet-Rich Plasma for improving hair density and thickness.

Lower LDL-c levels predict higher COVID-19 mortality.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Spironolactone effectively treats female pattern hair loss with few side effects.

Hair aging and loss are caused by genetics, hormones, environment, and grooming, with treatments like minoxidil effective for certain types of hair loss.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Most women with excessive hair growth in South India have hirsutism without a known cause, with common facial hair growth and some showing hormonal imbalances and polycystic ovaries.

Low-dose oral minoxidil is safe and effective for treating hair loss, with most side effects being mild and reversible.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Male pattern baldness involves genetics, hormones, and needs better treatments.

A blood pressure drug, diltiazem, may also help treat influenza.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Chesapeake Bay retrievers' hair loss is likely a breed-specific, hereditary condition linked to abnormal steroid levels and distinct skin changes.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

The document does not determine if adults with aphallia are fertile.

The document concludes that managing health issues like menopause, cardiovascular risk, and hair loss is crucial for promoting longevity in aging women.

Alopecia is caused by various factors, and new treatments like gene editing and regenerative medicine offer hope for personalized hair regrowth solutions.

PRP therapy may help with ovarian issues and fertility, but more research is needed.

Nanostructured lipid carriers are effective for treating hyperpigmentation in women aged 30-40.